These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27234692)

  • 1. A novel dominant negative mutation in the intracellular domain of GHR is associated with growth hormone insensitivity.
    Takagi M; Shinohara H; Nagashima Y; Hasegawa Y; Narumi S; Hasegawa T
    Clin Endocrinol (Oxf); 2016 Oct; 85(4):669-71. PubMed ID: 27234692
    [No Abstract]   [Full Text] [Related]  

  • 2. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor.
    Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ;
    Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical GH insensitivity syndrome and severe insulin-like growth factor-I deficiency resulting from compound heterozygous mutations of the GH receptor, including a novel frameshift mutation affecting the intracellular domain.
    Aisenberg J; Auyeung V; Pedro HF; Sugalski R; Chartoff A; Rothenberg R; Derr MA; Hwa V; Rosenfeld RG
    Horm Res Paediatr; 2010; 74(6):406-11. PubMed ID: 20606392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial growth-hormone insensitivity: the role of growth-hormone receptor mutations in idiopathic short stature.
    Goddard AD; Dowd P; Chernausek S; Geffner M; Gertner J; Hintz R; Hopwood N; Kaplan S; Plotnick L; Rogol A; Rosenfield R; Saenger P; Mauras N; Hershkopf R; Angulo M; Attie K
    J Pediatr; 1997 Jul; 131(1 Pt 2):S51-5. PubMed ID: 9255229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the human growth hormone receptor and IGF-I coding sequences in children with growth disorders.
    Obrepalska-Steplowska A; Kedzia A; Goździcka-Józefiak A; Jakubowicz M; Korman E
    J Pediatr Endocrinol Metab; 2003; 16(6):819-25. PubMed ID: 12948293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone insensitivity associated with a STAT5b mutation.
    Kofoed EM; Hwa V; Little B; Woods KA; Buckway CK; Tsubaki J; Pratt KL; Bezrodnik L; Jasper H; Tepper A; Heinrich JJ; Rosenfeld RG
    N Engl J Med; 2003 Sep; 349(12):1139-47. PubMed ID: 13679528
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of the intracellular signalling domain of the human growth hormone receptor in children with idiopathic short stature.
    Johnston LB; Pashankar F; Camacho-Hübner C; Savage MO; Clark AJ
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):463-9. PubMed ID: 10762289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone/IGF-I axis and growth hormone receptor mutations in idiopathic short stature.
    El Kholy M; Mella P; Rashad M; Buzi F; Meazza C; Zahra S; Elsedfy HH
    Horm Res Paediatr; 2011; 76(5):300-6. PubMed ID: 21846964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of the d3-growth hormone receptor (d3-GHR) polymorphism on the therapeutic effect of growth hormone replacement in children with idiopathic growth hormone deficiency in Poland.
    Szmit-Domagalska J; Petriczko E; Drozdzynska M; Adler G; Horodnicka-Jozwa A; Ciechanowicz A; Walczak M
    Neuro Endocrinol Lett; 2016 Sep; 37(4):282-288. PubMed ID: 27857044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between phenotype and genotype in growth hormone insensitivity syndrome.
    Woods KA; Clark AJ; Amselem S; Savage MO
    Acta Paediatr Suppl; 1999 Feb; 88(428):158-62; discussion 163. PubMed ID: 10102073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotype: genotype relationships in growth hormone insensitivity syndrome.
    Woods KA; Dastot F; Preece MA; Clark AJ; Postel-Vinay MC; Chatelain PG; Ranke MB; Rosenfeld RG; Amselem S; Savage MO
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3529-35. PubMed ID: 9360502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The exon 3-deleted/full-length growth hormone receptor polymorphism did not influence growth response to growth hormone therapy over two years in prepubertal short children born at term with adequate weight and length for gestational age.
    Carrascosa A; Audí L; Fernández-Cancio M; Esteban C; Andaluz P; Vilaró E; Clemente M; Yeste D; Albisu MA; Gussinyé M
    J Clin Endocrinol Metab; 2008 Mar; 93(3):764-70. PubMed ID: 18160465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone insensitivity syndrome due to point deletion and frame shift in the growth hormone receptor.
    Counts DR; Cutler GB
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1978-81. PubMed ID: 7775649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exon 3-deleted genotype of growth hormone receptor (GHRd3) positively influences IGF-1 increase at generation test in children with idiopathic short stature.
    Toyoshima MT; Castroneves LA; Costalonga EF; Mendonca BB; Arnhold IJ; Jorge AA
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):500-4. PubMed ID: 17555512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone (GH) insensitivity syndrome with high serum GH-binding protein levels caused by a heterozygous splice site mutation of the GH receptor gene producing a lack of intracellular domain.
    Iida K; Takahashi Y; Kaji H; Nose O; Okimura Y; Abe H; Chihara K
    J Clin Endocrinol Metab; 1998 Feb; 83(2):531-7. PubMed ID: 9467570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of clinical manifestations and genetic mutations in a child with Laron syndrome].
    Chang GY; Chen SK; Gu XF; Gong ZW; Zhang QG
    Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):930-3. PubMed ID: 24495765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone receptor sequence changes do not play a role in determining height in children with idiopathic short stature.
    Hujeirat Y; Hess O; Shalev S; Tenenbaum-Rakover Y
    Horm Res; 2006; 65(4):210-6. PubMed ID: 16582564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone (GH) dose, but not exon 3-deleted/full-length GH receptor polymorphism genotypes, influences growth response to two-year GH Therapy in Short Small-for-Gestational-Age Children.
    Carrascosa A; Audí L; Esteban C; Fernández-Cancio M; Andaluz P; Gussinyé M; Clemente M; Yeste D; Albisu MA
    J Clin Endocrinol Metab; 2008 Jan; 93(1):147-53. PubMed ID: 17925340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study Group.
    Goddard AD; Covello R; Luoh SM; Clackson T; Attie KM; Gesundheit N; Rundle AC; Wells JA; Carlsson LM
    N Engl J Med; 1995 Oct; 333(17):1093-8. PubMed ID: 7565946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New growth hormone receptor exon 9 mutation causes genetic short stature.
    Ayling RM; Ross RJ; Towner P; Von Laue S; Finidori J; Moutoussamy S; Buchanan CR; Clayton PE; Norman MR
    Acta Paediatr Suppl; 1999 Feb; 88(428):168-72; discussion 173. PubMed ID: 10102075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.